DHI insider files Form 144 to sell 30,000 shares valued at $5.47M

Rhea-AI Filing Summary

D.R. Horton Inc. (DHI) filed a Form 144 notice proposing the sale of 30,000 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of $5,466,412.07 and approximately 298,123,529 shares outstanding. The filing lists the shares being sold as previously acquired as stock awards between October 31, 2023 and April 20, 2024 from the company, with specific award lot sizes of 7,886; 8,413; 2,964; 5,761; and 4,976 shares. No securities were reported sold in the past three months. The filer attests they are not aware of undisclosed material adverse information.

Positive

• Sale routed through a registered broker (UBS) on the NYSE, indicating standard execution channels and compliance with market rules
• Securities to be sold were acquired as stock awards, suggesting the shares originate from compensation rather than external purchases

Negative

• Proposed sale size is 30,000 shares valued at $5,466,412.07, which represents a notable insider liquidity event though the filing does not state materiality relative to holder wealth
• No 10b5-1 plan date is disclosed in the filing, so it is unclear whether the sale is preplanned or discretionary

Insights

Financial Analyst

TL;DR: Routine insider sale notice for 30,000 shares valued at $5.47M; limited standalone market impact.

The Form 144 documents a proposed sale rather than a completed transaction, showing a block of 30,000 shares held via recent stock awards concentrated in multiple grant dates during late 2023 and early 2024. Because the filing does not report prior sales in the past three months and the sale is being routed through a major brokerage on the NYSE, this appears consistent with planned, disclosed insider liquidity rather than an emergency divestiture. Without accompanying operational or financial disclosures, the filing by itself conveys limited new information about company fundamentals.

Corporate Governance Expert

TL;DR: Governance process observed; sale by award recipient follows standard disclosure practices under Rule 144.

The notice identifies the securities as acquired through stock awards from the company across several dates, which implies compensation-related origin of the holdings. The signature attestation required by the form is present, and the use of a registered broker indicates a compliant execution channel. As a matter of governance, this filing documents transparent compliance with resale rules, but it does not include a trading plan date or other 10b5-1 details, so readers cannot confirm preplanned execution timing from this filing alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	30000	5466412.07	298123529	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/23/2024	Stock Award	Company - DR Horton Inc.			8413	03/23/2024	N/A
Common Stock	03/17/2024	Stock Award	Company - DR Horton Inc.			2964	03/17/2024	N/A
Common Stock	04/19/2024	Stock Award	04/19/2024			5761	04/20/2024	N/A
Common Stock	04/20/2024	Stock Award	Company - DR Horton Inc.			4976	04/20/2024	N/A
Common Stock	10/31/2023	Stock Award	Company - DR Horton Inc.			7886	10/31/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DHI Form 144 filed for 09/05/2025 report?

The filing reports a proposed sale of 30,000 common shares through UBS Financial Services on the NYSE with an aggregate market value of $5,466,412.07.

How were the 30,000 DHI shares acquired?

The shares were recorded as stock awards from D.R. Horton with grant/acquisition dates ranging from 10/31/2023 to 04/20/2024 across five award lots.

Does the filing show any shares sold in the past three months?

No. The filing indicates "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed DHI sale?

The broker listed is UBS Financial Services Inc located at 1000 Harbor Blvd, Weehawken, NJ, for execution on the NYSE.

Did the filer make the required attestation about undisclosed material information?

Yes. The filer signs the Form 144 attesting they do not know any material adverse information about the issuer that has not been publicly disclosed.